PTPN22 and autoimmune disease: We have previously shown that both anti-CD28 and soluble TNFα inhibited the expression of PTPN22 [19], a gene that is associated with several autoimmune diseases [20], but only anti-CD28 promoted the production of IL-17A/F in anti-CD3 stimulated PBMCs.